OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
March 07, 2023
The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.
Stats point to a 14.9% decline compared to January of last year.
March 06, 2023
Initiative intends to facilitate regulatory compliance within the pharma distribution space.
March 03, 2023
With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.
March 02, 2023
Hoping to accelerate the drug delivery process, production is expected to begin as early as 2025.
Following numerous successful trial runs, vaccine production is expected to reach 700 million.
March 01, 2023
Expansion expected to increase global capacity by 75%.
Enhancements to help keep products frozen for over 144 hours, company says.
Joint venture revolves around around the use of raw materials for the development—and ultimately commercialization—of therapies.
February 27, 2023
New 25,000 square-foot facility will help grow customers’ gene therapy programs.